Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical application of formoterol/budesonide powder for inhalation

A technology for inhalation and medicine, which is applied in the medical application field of budesonide formoterol powder inhalation, can solve problems such as lung injury of patients, and achieve the effects of small dosage, obvious effect and small side effects

Inactive Publication Date: 2011-03-30
张贵
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But now the use of this inhaler is to use this drug for treatment when asthma attacks, which will cause certain damage to the patient's lungs. It would be better if there is a drug that can prevent the attack of asthma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0009] Budesonide and formoterol powder inhalation can be used to prevent the onset of allergic asthma. Patients with allergies during the Spring Festival can inhale for two months, and patients with allergies in autumn can stop inhaling after the Bailu solar term, so as to prevent allergic asthma attacks.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical application of formoterol / budesonide powder for inhalation, in particular to an application of the preparation of the medicine for preventing asthmatic attack. The medicine is taken through oral inhalation to achieve the aim of local delivery; and compared with the systemic administration, the dosage is small, the side effects are small and the effect is obvious. In a test, after fifty patients with asthma caused by allergic constitution inhale the medicine twice per day one month before the allergy season and take for two months, forty five patients do not suffer asthmatic attack in the allergy season and five patients have mild symptom of expectoration but do not have obvious symptoms of asthmatic attack. Therefore, the obvious effect rate is up to 90% and the effective rate is up to 100%.

Description

technical field [0001] The invention relates to the medical application of budesonide formoterol powder inhalation in preventing asthma attacks Background technique [0002] Asthma caused by allergies is usually seasonal, usually in the seasons of spring and late summer and early autumn. Patients are often allergic to a certain plant powder in these two seasons, leading to allergic rhinitis or asthma. Symptoms may be Lasts about a month. [0003] Budesonide formoterol powder inhalation has been used in the treatment of asthma for many years, and the effect is very good. synergy. The mechanisms of action of the two ingredients are as follows: Budesonide: Budesonide inhaled at the recommended dose has the anti-inflammatory effect of glucocorticoids on the lungs, can relieve asthma symptoms, slow down the progression of the disease, and has relatively fewer side effects than systemic medication. Formoterol is a selective β2-adrenoceptor agonist that relaxes bronchial smooth ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/58A61K31/167A61K9/72A61K9/14A61P11/06
Inventor 张贵
Owner 张贵
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products